How the Moderna vaccine stacks up against Pfizer/BioNTech's

U.S. regulators authorized Moderna Inc's COVID-19 vaccine for emergency use, a week after granting the first U.S. authorization to Pfizer Inc and BioNTech SE's coronavirus shot. The following is a comparison of the two vaccines and what to expect as both become available:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37vv4S8
via IFTTT